MALARIA RESEARCH INSTITUTE
Leading Science for a Malaria-Free World
Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.
The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.
World Malaria Day Symposium 2024
Join us on Thursday, April 25 for this full-day, in-person, complimentary symposium. It is among the largest World Malaria Day events in North America. Submit abstracts for poster consideration by March 24. Please register now.
News and Noteworthy
Innovation Advance | Dimopoulos Lab
The international team of researchers led by JHMRI Deputy Director George Dimopoulos with Professor Charles Wondji at the CRID in Cameroon worked with Hyris to develop a new, simple, portable device that delivers early, cost-effective detection of mosquito resistance to insecticides.
Latest Research Advance| Jacob-Lorena Lab
Scientists weaponize the symbiotic bacteria in mosquitoes against the deadly diseases they transmit.
Applications Welcome
Two full-time, tenure-track faculty positions are open. Seeking candidates that use ‘omics’ technologies and systems biology approaches in their studies of the pathogen, the host, or vector.
19
Full-time faculty
130+
Pilot grants awarded
250+
Mentions in major news outlets since 2020
750+
Publications and articles in scientific journals
Malaria Research in Action | A Video
Scientists at the Johns Hopkins Malaria Research Institute are working to better understand and fight malaria from the labs in Baltimore to the field in Southern and Central Africa.